JPS6313224Y2 - - Google Patents
Info
- Publication number
- JPS6313224Y2 JPS6313224Y2 JP1983126908U JP12690883U JPS6313224Y2 JP S6313224 Y2 JPS6313224 Y2 JP S6313224Y2 JP 1983126908 U JP1983126908 U JP 1983126908U JP 12690883 U JP12690883 U JP 12690883U JP S6313224 Y2 JPS6313224 Y2 JP S6313224Y2
- Authority
- JP
- Japan
- Prior art keywords
- parts
- poultice
- drug
- layer
- adhesive layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 13
- 239000010410 layer Substances 0.000 claims description 8
- 239000012790 adhesive layer Substances 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 239000000463 material Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- -1 alkaline earth metal salt Chemical class 0.000 description 6
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 239000005844 Thymol Substances 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 229960000790 thymol Drugs 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 150000003902 salicylic acid esters Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 241001106067 Atropa Species 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
【考案の詳細な説明】
従来パツプ剤は織布、不織布等の面にカオリ
ン、ベントナイト等の基材にソルビトール、グリ
セリン、プロピレングリコール、アルカリ土類金
属塩等の湿潤剤、サリチル酸メチル、ハツカ油、
メントール、チモール、カンフル等の薬剤その他
の所要材料を配合したパツプ剤層を設けている。
これらパツプ剤の効果は配合薬剤の鎮痛、消炎作
用と水による冷却作用によつて発揮されるものと
考えられている。このためパツプ剤は薬剤の放出
性及び水による冷却性の改善と共にパツプ剤の密
着性の付与に関する種々の工夫がなされている
が、従来のパツプ剤の如く水を含有する系では、
パツプ剤層の接着力と凝集力(剥離時にパツプ剤
が皮膚に残留しないための凝集力)との調整が困
難で、その釣合いの良いものが得がたいほか、水
に対し不安定なサリチル酸エステル系薬剤は経時
変化の問題がある等の不利があつた。[Detailed description of the invention] Conventional bulges have been prepared by adding a base material such as kaolin or bentonite to the surface of a woven or non-woven fabric, a wetting agent such as sorbitol, glycerin, propylene glycol, or an alkaline earth metal salt, methyl salicylate, peppermint oil, or the like.
A poultice layer containing drugs such as menthol, thymol, camphor, and other necessary materials is provided.
The effects of these poultices are thought to be exerted by the analgesic and anti-inflammatory effects of the combined drugs and the cooling effect of water. For this reason, various efforts have been made to improve the drug release properties and water-based cooling properties of poultices, as well as to provide adhesiveness to the poultices.However, in systems containing water such as conventional poultices,
It is difficult to adjust the adhesion and cohesive force of the poultice layer (the cohesive force that prevents the poultice from remaining on the skin when peeled off), and it is difficult to obtain a well-balanced product. In addition, salicylic acid ester drugs are unstable in water. However, there were disadvantages such as the problem of deterioration over time.
本案は皮膚に対する貼着作用と鎮痛消炎作用を
する薬剤含有粘着剤層と冷却作用をする含水ゲル
化物を有する複合体に形成したもので、薬剤の放
出性、患部に対する冷却性、皮膚との密着性等の
極めて良好なものを提供しようとするものであ
る。 This product is formed into a composite material that has a drug-containing adhesive layer that has adhesion to the skin and analgesic and anti-inflammatory effects, and a hydrous gel that has a cooling effect. The aim is to provide extremely good quality and quality.
以下実施例について説明すると、粘着剤に対し
剥離性を有するシート材1の剥離性な面に薬剤入
り粘着剤層2を設け、該粘着剤層の上面にゼラチ
ン、カゼイン等の蛋白質系含水ゲル化物層4を設
けてパツプ剤を形成している。 To explain an example below, a drug-containing adhesive layer 2 is provided on the releasable surface of a sheet material 1 that is releasable to an adhesive, and a protein-based hydrogel such as gelatin or casein is provided on the upper surface of the adhesive layer. A layer 4 is provided to form a poultice.
上記の含水ゲル化物にはゼラチン、カゼイン、
等の蛋白質をゲル化したものがあり、これらゲル
化物には、必要に応じてカオリン、ベントナイ
ト、炭酸カルシウム、その他の無機物質粉末、プ
ロピレングリコール、ソルビトール、グリセリ
ン、塩化マグネシウムその他の吸湿性物質、チモ
ールその他の防腐剤、その他従来のパツプ剤層に
使用されている各種物質の適宜量が配合できる。
上記の含水ゲル化物質を形成する原料配合剤を示
すと、ゼラチン12部(重量以下同様)、グリセリ
ン55部、炭酸カルシウム18部、酸化チタン5部、
塩化マグネシウム2.5部、サンウエツト1M300(三
洋化成KK商品名)0.5部、ポリアクリル酸ソーダ
4部、流動パラフイン2部、ツイン80(花王アト
ラスKK商品名)1部、グルタールアルデヒド0.1
部、チモール0.5部、精製水99.4部があり、上記
配合材料を適当に混合し、これを例えば約800
g/m2の割で前記粘着剤層上に塗布、冷却、固
化、含水ゲル状となし、これを更に1週間放置し
て安定化した含水ゲル化物質が形成できる。 The above hydrogelated products include gelatin, casein,
These gels may contain kaolin, bentonite, calcium carbonate, other inorganic substance powders, propylene glycol, sorbitol, glycerin, magnesium chloride and other hygroscopic substances, thymol, etc., as necessary. Appropriate amounts of other preservatives and other various substances used in conventional poultice layers can be added.
The raw materials used to form the above-mentioned water-containing gelatinized substance include 12 parts of gelatin (the same applies below weight), 55 parts of glycerin, 18 parts of calcium carbonate, 5 parts of titanium oxide,
2.5 parts of magnesium chloride, 0.5 parts of Sunwet 1M300 (Sanyo Kasei KK brand name), 4 parts of sodium polyacrylate, 2 parts of liquid paraffin, 1 part of Twin 80 (Kao Atlas KK brand name), 0.1 part of glutaraldehyde.
1 part, 0.5 parts of thymol, and 99.4 parts of purified water.
g/m 2 on the pressure-sensitive adhesive layer, cooled, solidified, and formed into a hydrogel, and left for another week to form a stabilized hydrogel.
前記薬剤には、サリチル酸メチル、サリチル酸
グリコール、メントール、カンフアー、ボルネオ
ール、ノニル酸ワニリルアミド、ハツカ油、トウ
ガラシエキス、ベラドンナエキス、ロートエキ
ス、ジフエンヒドラミンその他の消炎、鎮痛、刺
戟等の効果を有する物質があり、薬剤を配合する
粘着剤はゴム系、アクリル系、ビニルエーテル
系、シリコーン系等があり、目的に応じて適宜使
用できる。又上記剥離性シート材1にはシリコー
ン、高級脂肪酸等で処理した紙のほか、必要に応
じて前記剥離剤で処理したポリエチレン積層紙、
ポリエチレン、ポリプロピレン、ポリエステル、
アルミニウム箔積層ポリエチレンその他のプラス
チツクフイルムがある。 The drugs include methyl salicylate, glycol salicylate, menthol, camphor, borneol, nonylic acid vanillylamide, pepper oil, capsicum extract, belladonna extract, rotisserie extract, diphenhydramine, and other substances that have anti-inflammatory, analgesic, and stimulant effects. There are various types of adhesives that contain chemicals, such as rubber-based, acrylic-based, vinyl ether-based, and silicone-based adhesives, which can be used as appropriate depending on the purpose. In addition to paper treated with silicone, higher fatty acids, etc., the releasable sheet material 1 may also include polyethylene laminated paper treated with the above-mentioned release agent, if necessary.
polyethylene, polypropylene, polyester,
Aluminum foil laminated polyethylene and other plastic films are available.
上記の如く形成されたパツプ剤は所要大きさに
して、その剥離性シート材を剥がしその薬剤入り
粘着剤層を介して患部に貼りつけて使用される。
このパツプ剤はそのままの大きさ若しくは所要の
大きさ例えば14×10cm角等に裁断等して、そのゲ
ル化物質の上面をポリエチレンその他のフイルム
で被覆若しくは被覆せず、その適宜数、例えば5
枚をアルミニウム箔積層フイルム製等の袋に密封
して市場に供給する。 The poultice formed as described above is used by cutting it into a required size, peeling off the releasable sheet material, and pasting it on the affected area via the drug-containing adhesive layer.
This poultice can be used as it is or cut into pieces of the required size, e.g. 14 x 10 cm square, and the upper surface of the gelled substance may or may not be covered with polyethylene or other film, and the appropriate number of films, e.g.
The sheets are sealed in bags made of aluminum foil laminated film and supplied to the market.
本案は上述の如く構成されているので、患部皮
膚面との接着は粘着テープ並みの接着力(対ベー
クライト接着力約300g/30mm)で強固に付着で
きると共に薬剤は患部に近接してその作用も顕著
になり、小量の薬剤の使用ですぐれた効果が得ら
れる上薬剤は水分に分散することがないので、加
水分解も起らずサリチル酸エステル系薬剤も使用
でき、含水ゲル化物層による冷却作用と相俟つて
極めて大なる治療効果を奏する。 Since the present invention is constructed as described above, it can be firmly attached to the affected skin surface with an adhesive force comparable to that of adhesive tape (adhesive force to Bakelite of about 300 g/30 mm), and the drug can be placed close to the affected area and its effect can be maintained. In addition, since the drug does not disperse in water, no hydrolysis occurs, and salicylic acid ester drugs can also be used, and the cooling effect due to the hydrous gel layer Together with this, it has an extremely large therapeutic effect.
図面は本案の実施例を示し、第1図は斜面図、
第2図は断面図。
1は剥離性シート材、2は薬剤含有粘着剤層、
4は含水ゲル化物層。
The drawings show an example of the present invention, and Figure 1 is a slope view;
Figure 2 is a sectional view. 1 is a removable sheet material, 2 is a drug-containing adhesive layer,
4 is a hydrous gelled material layer.
Claims (1)
の蛋白質系含水ゲル化物層を形成したパツプ剤。 A poultice with a hydrogelled protein layer such as gelatin or casein formed on a drug-containing adhesive layer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12690883U JPS6034822U (en) | 1983-08-18 | 1983-08-18 | poultice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12690883U JPS6034822U (en) | 1983-08-18 | 1983-08-18 | poultice |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6034822U JPS6034822U (en) | 1985-03-09 |
JPS6313224Y2 true JPS6313224Y2 (en) | 1988-04-14 |
Family
ID=30288412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12690883U Granted JPS6034822U (en) | 1983-08-18 | 1983-08-18 | poultice |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6034822U (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6148081B2 (en) * | 2013-06-18 | 2017-06-14 | 日本電子精機株式会社 | A patch for covering a curved surface and / or an uneven portion of the body |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55129056A (en) * | 1979-03-26 | 1980-10-06 | Nitto Electric Ind Co | Poultice |
-
1983
- 1983-08-18 JP JP12690883U patent/JPS6034822U/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55129056A (en) * | 1979-03-26 | 1980-10-06 | Nitto Electric Ind Co | Poultice |
Also Published As
Publication number | Publication date |
---|---|
JPS6034822U (en) | 1985-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3335569B2 (en) | Sheet-shaped pack package and manufacturing method thereof | |
US5008110A (en) | Storage-stable transdermal patch | |
AU603531B2 (en) | Device for administering an active agent to the skin or mucosa | |
JP2527547B2 (en) | Therapeutic device for drug administration | |
ES2224102T3 (en) | NON-OCLUSIVE ADHESIVE PATCH TO APPLY SKIN MEDICATION. | |
EP0356614B1 (en) | Dermal applicator | |
US5064422A (en) | Twin patch applicator | |
KR100267442B1 (en) | Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis | |
JP2000517343A (en) | Pressure sensitive adhesive matrix patch for transdermal delivery of pharmaceutical salts | |
JPS60168450A (en) | Bandage | |
JP4139689B2 (en) | Packaging system for transdermal drug delivery system | |
US4788064A (en) | Transdermal delivery system | |
JPS6324959A (en) | Partitioned percutaneous delivery system | |
JPS6313224Y2 (en) | ||
WO2005084255A2 (en) | Aspirin transdermal patch | |
FI120719B (en) | A process for the preparation of a transdermal system containing acetylsalicylic acid | |
JP2781016B2 (en) | Transdermal formulation | |
JPH09299445A (en) | Packed body for plaster agent containing medicine | |
JPS63200760A (en) | Production of sheet like adhesive | |
JP2882650B2 (en) | Semi-solid drug applicator | |
JPH0754259Y2 (en) | Skin patch | |
JPH0711131Y2 (en) | External patch | |
JPH0538011Y2 (en) | ||
JP4327958B2 (en) | Cooling patch | |
JPH0357251Y2 (en) |